Bookmark Kaumudi Online  Bookmark this site  Editor@Kaumudi  |  Marketing  Print Advt rates  |  Calendar 2012        Go!    
 
 
October 19, Thursday 2017 3:40 AM       

       HEADLINES: Solar case: Discontent brews among police officers                                              Minister Thomas Chandy to go on leave                                              PRD skips PU Chithra’s picture                                              I'm accepting Amit Shah's challenge: CM                                              Amit Shah came like lion, returned like rat: Kodiyeri                                              Irani asks Congress to come clean on Bofors                                              Over 1,200 kg firecrackers seized, 29 held post SC ban on fireworks sale                                              Taj Mahal is a mausoleum built on Shiva temple: Vinay Katiyar                                              Dogs in Nepal get VIP treatment on second day of Tihar                                              Brazil drub Honduras 3-0, face Germany in quarterfinals                                              Katsumi hopes to win maiden I-League for East Bengal                                              De Villiers hits 176 as South Africa score 353/6 vs B'desh                                              Kaumudi Facebook
       SCI&TECH Next Article: Mysterious 'Higgs Bison' species identified  
       Male birth control shots may lower pregnancy odds: study
 
         Posted on :19:04:16 Oct 28, 2016
   
A A
       Last edited on:19:04:16 Oct 28, 2016
         Tags: Male birth control, lower pregnancy odds, stu
 
GENEVA: An experimental birth control vaccine for men can effectively prevent pregnancy in their female partners by lowering sperm count, scientists including those from India have found. Researchers are working to perfect the combination of hormonal contraceptives to reduce the risk of mild to moderate side effects, including depression and other mood disorders.
 
"The study found it is possible to have a hormonal contraceptive for men that reduces the risk of unplanned pregnancies in the partners of men who use it," said Mario Philip Reyes Festin, from the World Health Organisation (WHO) in Switzerland. "Our findings confirmed the efficacy of this contraceptive method previously seen in small studies," said Festin.
 
Researchers, including Man Mohan Misro of the National Institute of Health and Family Welfare in New Delhi, tested the safety and effectiveness of injectable contraceptives in 320 healthy men ages 18 to 45.
 
The participants had all been in monogamous relationships with female partners between the ages of 18 and 38 for at least a year. The men underwent testing to ensure they had a normal sperm count at the start of the study.
 
The men received injections of 200 milligrams of a long-acting progestogen called norethisterone enanthate (NET-EN) and 1,000 milligrams of a long-acting androgen called testosterone undecanoate (TU) for up to 26 weeks to suppress their sperm counts.
 
Healthcare professionals gave the men two injections every eight weeks. Participants initially provided semen samples after eight and 12 weeks in the suppression phase and then every 2 weeks until they met the criteria for the next phase.
 
During this time, the couples were instructed to use other non-hormonal birth control methods. Once a participant's sperm count was lowered to less than one million/ml in two consecutive tests, the couple was asked to rely on the injections for birth control.
 
During this period known as the efficacy phase of the study, the men continued to receive injections every eight weeks for up to 56 weeks. Participants provided semen samples every eight weeks to ensure their sperm counts stayed low. Once the participants stopped receiving the injections, they were monitored to see how quickly their sperm counts recovered.
 
The hormones were effective in reducing the sperm count to one million/ml or less within 24 weeks in 274 of the participants. The contraceptive method was effective in nearly 96 per cent of continuing users. Only four pregnancies occurred among the men's partners during the efficacy phase of the study.
 
Researchers stopped enrolling new participants in the study in 2011 due to the rate of adverse events, particularly depression and other mood disorders, reported by the participants. The men reported side effects including injection site pain, muscle pain, increased libido and acne. The study was published in the Journal of Clinical Endocrinology and Metabolism.
A A
       SCI&TECH
Next Article: Mysterious 'Higgs Bison' species identified
 
 
SCI&TECH HEADLINES
Stress as unhealthy as junk food  
Planet Nine does exist in solar system: NASA  
Blame these hormones if your dog is getting aggressive  
Save big on Infinix Note 4, Hot 4 Pro during Flipkart's 'Big Diwali Sale'  
Even modest exposure to oil can harm coastal, marine birds  
Starfish, anemones protect ecosystems from climate change  
Skipping breakfast may help to shed those extra kilos  
Dozing off during lecture? Blame your neurons  
Google's Pixel 2 promotes safe driving through automatic 'do not disturb' mode  
Researchers create molecule that could kill HIV  
Google unveils new moves to boost struggling news organizations  
Here's how zebrafish get its stripes  
Facebook to introduce facial recognition for account security  
LG launches smartphone to 'keep mosquitos at bay'  
New spider species named after DiCaprio, Obama  
Astrophysicists make music from Saturn's moons, rings  
Rooter includes Kabbadi, F1 under one roof  
Orbiting supermassive black holes discovered for first time  
Theweightmonitor.com launches mobile app for easier access to one-stop weight management platform  
New drug to treat blood cancer developed  
Threat of asteroid impact looming over Earth: experts  
Hottest known planet in universe discovered  
Wireless, battery-less pacemaker developed  
'Manned missions to Moon, Mars may face medical emergencies'  
Ransomware threat: Centre activates mechanism to prevent ‘Wannacry’ cyber attack  
 
Is there any logic in making Dileep the first accused in the actress attack case?
yes
 
no
 
no opinion
 
 
 
Home Kerala India World Business Sports Sci&Tech Education Automobile CityNews Movies Environment Letters 
© Copyright keralakaumudi Online 2011  |  Reproduction in whole or in part without written permission is prohibited.
Head Office Address: Kaumudi Buildings, Pettah P.O, Trivandrum - 695024, India.
Online queries talk to Deepu Sasidharan, + 91 98472 38959 or Email deepu[at]kaumudi.com
Customer Service -Advertisement Disclaimer Statement   |  Copyright Policy